造影超音波市場規模、佔有率和成長分析：按產品類型、造影劑類型、應用、最終用戶、技術、給藥途徑和地區分類－2026-2033年產業預測

2024 年全球造影超音波市場價值為 21 億美元，預計到 2025 年將成長至 22.2 億美元，到 2033 年將成長至 35.2 億美元，在預測期（2026-2033 年）內複合年成長率為 5.9%。

全球造影超音波（CEUS）市場正經歷顯著成長，這主要得益於其利用微氣泡造影劑增強血管和組織顯影的能力。臨床醫生擴大採用CEUS，尤其是在肝病學、心臟病學和腫瘤學等領域，因為它能夠即時、無輻射地評估器官血流。 CEUS是CT和MRI的一種經濟有效的替代方案，能夠提高病患安全性。近期技術進步和監管核准正在推動CEUS的普及，而更廣泛的報銷選擇也促進了臨床醫生的採用。人工智慧的整合透過影像銳利化、自動化分析和減少操作者差異，進一步提高了診斷準確性，從而改變了市場格局。這種創新方法能夠實現更快、更安全的影像診斷，並擴展了CEUS的應用範圍，從而推動了可攜式系統和介入引導工具的投資和研發。

全球造影超音波市場成長要素

全球造影超音波市場的主要促進因素之一是慢性疾病（尤其是心血管疾病和癌症）盛行率的不斷上升。這些疾病需要先進的影像技術進行精準診斷和監測。隨著醫療專業人員日益認知到造影超音波的優勢，例如其非侵入性、即時成像能力以及與傳統成像方法相比更低的有害輻射暴露風險，對這些技術的需求正在激增。此外，超音波技術的不斷進步和新型造影劑的研發正在提高診斷準確性，並拓展超音波在各種臨床環境中的應用，從而進一步推動市場成長。

全球造影超音波市場面臨的限制因素

全球造影超音波市場的主要限制因素之一是先進超音波影像成像設備和造影劑的高成本。這些經濟壁壘限制了這些技術的普及，尤其是在醫療預算有限的發展中地區。此外，能夠操作先進超音波系統的訓練有素人員短缺也可能阻礙造影超音波的廣泛應用。對病患安全和造影劑潛在副作用的擔憂也使醫療專業人員猶豫不決，最終限制了各種醫療機構的整體市場成長。

全球造影超音波市場趨勢

全球超音波造影正經歷一個顯著趨勢：人工智慧 (AI) 被整合到診斷影像工作流程中，從根本上改變了超音波檢查的執行方式。 AI 技術簡化了影像擷取、病灶表徵和造影劑動力學分析等各種流程，最終促進了不同操作者之間的標準化。這種整合使得臨床決策支援工具的差異性降至最低，從而在臨床環境中實現更快、更可靠的診斷。隨著供應商專注於軟體夥伴關係和嵌入式分析功能，對可重複性和擴充性的需求日益成長，推動了其在臨床實踐中的應用，並提高了醫療保健工作流程的整體效率。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球造影超音波市場規模：依產品類型分類

• 超音波造影
• 超音波診斷設備
• 軟體和影像平台

全球造影超音波市場規模：依造影劑類型分類

• 微氣泡造影劑
• 奈米造影劑
• 其他

全球造影超音波市場規模：按應用領域分類

• 循環系統
• 放射科
• 腫瘤學
• 肝病學
• 腎臟病學
• 其他

全球造影超音波市場規模：依最終用戶分類

• 醫院
• 診斷影像中心
• 門診手術中心
• 專科診所

全球造影超音波市場規模：按技術分類

• 多普勒超音波
• 諧波成像
• 灌注影像
• 分子影像

全球造影超音波市場規模：依給藥途徑分類

• 靜脈
• 腔內

全球造影超音波市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• GE HealthCare
• Siemens Healthineers
• Philips
• Canon Medical Systems
• FUJIFILM Healthcare
• Samsung Medison
• Mindray
• Bracco Imaging
• Lantheus Holdings
• Bayer
• Esaote
• Hitachi Healthcare
• Konica Minolta Healthcare
• Shenzhen Landwind Industry
• SonoScape Medical
• CHISON Medical Technologies
• SuperSonic Imagine
• Carestream Health
• Terason
• Shantou Institute of Ultrasonic Instruments

結論與建議

Global Contrast Enhanced Ultrasound Market size was valued at USD 2.1 Billion in 2024 and is poised to grow from USD 2.22 Billion in 2025 to USD 3.52 Billion by 2033, growing at a CAGR of 5.9% during the forecast period (2026-2033).

The global contrast-enhanced ultrasound (CEUS) market is experiencing significant growth driven by its ability to enhance vascular and tissue visualization using microbubble contrast agents. Clinicians are increasingly adopting CEUS for its real-time, radiation-free assessment of organ perfusion, particularly in fields like hepatology, cardiology, and oncology. CEUS serves as a cost-effective alternative to CT and MRI, improving patient safety. Recent advancements in technology and regulatory approvals have bolstered its uptake, while expanding reimbursement options enhance clinician adoption. AI integration is further transforming the landscape by improving diagnostic accuracy through enhanced image clarity, automated analysis, and reduced operator variability. This innovative approach supports faster, safer imaging and broadens CEUS applications, thus driving investment and development in portable systems and interventional guidance tools.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contrast Enhanced Ultrasound market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contrast Enhanced Ultrasound Market Segments Analysis

Global contrast enhanced ultrasound market is segmented by product type, contrast agent type, application, end user, technology, route of administration and region. Based on product type, the market is segmented into Ultrasound Contrast Agents, Ultrasound Systems and Software & Imaging Platforms. Based on contrast agent type, the market is segmented into Microbubble Contrast Agents, Nanoparticle Contrast Agents and Others. Based on application, the market is segmented into Cardiology, Radiology, Oncology, Hepatology, Nephrology and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers and Specialty Clinics. Based on technology, the market is segmented into Doppler Ultrasound, Harmonic Imaging, Perfusion Imaging and Molecular Imaging. Based on route of administration, the market is segmented into Intravenous and Intracavitary. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Contrast Enhanced Ultrasound Market

One key market driver for the global contrast-enhanced ultrasound market is the rising prevalence of chronic diseases, particularly cardiovascular disorders and cancers, which necessitate advanced imaging techniques for accurate diagnosis and monitoring. As healthcare providers increasingly recognize the advantages of contrast-enhanced ultrasound, including its non-invasive nature, real-time imaging capabilities, and reduced risk of harmful radiation exposure compared to traditional imaging methods, demand for these technologies is surging. Additionally, the ongoing advancements in ultrasound technology and the development of novel contrast agents are enhancing diagnostic accuracy and expanding the applicability of ultrasound in various clinical settings, further driving market growth.

Restraints in the Global Contrast Enhanced Ultrasound Market

One key market restraint for the global contrast-enhanced ultrasound market is the high cost associated with advanced ultrasound imaging equipment and contrast agents. The financial barriers limit the accessibility of these technologies, particularly in developing regions where healthcare budgets are constrained. Additionally, there may be a lack of trained personnel to operate sophisticated ultrasound systems, hindering the widespread adoption of contrast-enhanced procedures. Concerns regarding patient safety and potential adverse reactions to contrast agents also contribute to hesitance among healthcare providers, thus restraining the overall growth of the market in various healthcare settings.

Market Trends of the Global Contrast Enhanced Ultrasound Market

The Global Contrast Enhanced Ultrasound market is witnessing a significant trend towards the integration of artificial intelligence into imaging workflows, fundamentally transforming how ultrasound procedures are conducted. AI technology streamlines various processes such as image acquisition, lesion characterization, and contrast dynamics interpretation, ultimately enhancing standardization across different operators. This integration facilitates clinical decision support tools that minimize variability, resulting in faster and more reliable diagnoses right at the point of care. As vendors increasingly focus on software partnerships and embedded analytics, there is a growing demand for reproducibility and scalability, driving broader clinical adoption and improving overall workflow efficiency within healthcare settings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Contrast Enhanced Ultrasound Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Ultrasound Contrast Agents
• Ultrasound Systems
• Software & Imaging Platforms

Global Contrast Enhanced Ultrasound Market Size by Contrast Agent Type & CAGR (2026-2033)

• Market Overview
• Microbubble Contrast Agents
• Nanoparticle Contrast Agents
• Others

Global Contrast Enhanced Ultrasound Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cardiology
• Radiology
• Oncology
• Hepatology
• Nephrology
• Others

Global Contrast Enhanced Ultrasound Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers
• Specialty Clinics

Global Contrast Enhanced Ultrasound Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Doppler Ultrasound
• Harmonic Imaging
• Perfusion Imaging
• Molecular Imaging

Global Contrast Enhanced Ultrasound Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Intravenous
• Intracavitary

Global Contrast Enhanced Ultrasound Market Size & CAGR (2026-2033)

• North America (Product Type, Contrast Agent Type, Application, End User, Technology, Route of Administration)
  • US
  • Canada
• Europe (Product Type, Contrast Agent Type, Application, End User, Technology, Route of Administration)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Contrast Agent Type, Application, End User, Technology, Route of Administration)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Contrast Agent Type, Application, End User, Technology, Route of Administration)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Contrast Agent Type, Application, End User, Technology, Route of Administration)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GE HealthCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Medison
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esaote
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Konica Minolta Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Landwind Industry
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SonoScape Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CHISON Medical Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SuperSonic Imagine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carestream Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terason
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shantou Institute of Ultrasonic Instruments
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations